Doctors question BPC-157 health risks due to lack of human trials Doctors are using a regulatory gap to prescribe an unauthorized peptide Phillips, at McMaster University, says the lack of human trials raises serious questions about BPC-157's potential health risks
AUF1 protects against ferroptosis to alleviate sepsis-induced acute lung injury by regulating NRF2 and ATF3
But "any time" does not mean "all times are equal." It means the manufacturer did not find a statistically significant difference in primary endpoints based on timing in their pivotal trials
(334) assessed the antioxidant potential of three series of curcumin derivatives
The ferritin heavy chain (FTH) effectively sequesters pro-oxidative Fe +2 that would otherwise participate in the Fenton reaction (Vile and Tyrrell, 1993)
Our medical providers, leadership team, and clinicians are trained in the science and application of advanced therapies, such as NAD+ and 5-Amino-1MQ, and can help determine whether this approach or a different protocol is the right fit for your body, goals, and timeline